| ABT |
Abbott Laboratories |
72%
|
Reciprocal relationship from ABT graph: Reciprocal relationship from PLSE graph: Reciprocal relationship from ABT graph: Reciprocal relationship from PLSE graph: ucted by Professor Stefano Spiezia at… |
| ABT |
Abbott Laboratories |
72%
|
ucted by Professor Stefano Spiezia at the Ospedale del Mare in Naples, Italy, to help us better understand and confirm the mechanism of action and tissue response of nsPFA energy in internal organs s… |
| BSX |
Boston Scientific Corporation |
72%
|
Reciprocal relationship from BSX graph: Reciprocal relationship from PLSE graph: Reciprocal relationship from BSX graph: Reciprocal relationship from PLSE graph: ucted by Professor Stefano Spiezia at… |
| BSX |
Boston Scientific Corporation |
72%
|
ucted by Professor Stefano Spiezia at the Ospedale del Mare in Naples, Italy, to help us better understand and confirm the mechanism of action and tissue response of nsPFA energy in internal organs s… |
| JNJ |
Johnson & Johnson |
72%
|
ucted by Professor Stefano Spiezia at the Ospedale del Mare in Naples, Italy, to help us better understand and confirm the mechanism of action and tissue response of nsPFA energy in internal organs s… |
| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from PLSE graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from PLSE graph: Reciprocal relationship from JNJ grap… |
| MDT |
Medtronic plc |
72%
|
Reciprocal relationship from MDT graph: Reciprocal relationship from PLSE graph: ucted by Professor Stefano Spiezia at the Ospedale del Mare in Naples, Italy, to help us better understand and confirm… |
| MDT |
Medtronic plc |
72%
|
ucted by Professor Stefano Spiezia at the Ospedale del Mare in Naples, Italy, to help us better understand and confirm the mechanism of action and tissue response of nsPFA energy in internal organs s… |
| MMSI |
Merit Medical Systems, Inc. |
72%
|
lly invasive procedures. For example, Abbott Laboratories, AtriCure, Inc., Boston Scientific Corporation, Johnson & Johnson (Biosense Webster), Medtronic plc, and several other companies all sell abl… |
| MMSI |
Merit Medical Systems, Inc. |
72%
|
Reciprocal relationship from MMSI graph: Reciprocal relationship from PLSE graph: lly invasive procedures. For example, Abbott Laboratories, AtriCure, Inc., Boston Scientific Corporation, Johnson & J… |
| SMMT |
Summit Therapeutics Inc. |
72%
|
on an ongoing basis. Although we cannot predict the ultimate impact of any such new laws, they will likely result in additional costs and may require us to change how we manufacture our products, whi… |
| SMMT |
Summit Therapeutics Inc. |
72%
|
Reciprocal relationship from SMMT graph: Reciprocal relationship from PLSE graph: on an ongoing basis. Although we cannot predict the ultimate impact of any such new laws, they will likely result in … |
| ABBOTT-LABORATORIES-ATRICURE-INC-BOSTON-SCIENTIF |
ABBOTT-LABORATORIES-ATRICURE-INC-BOSTON-SCIENTIF |
62%
|
lly invasive procedures. For example, Abbott Laboratories, AtriCure, Inc., Boston Scientific Corporation, Johnson & Johnson (Biosense Webster), Medtronic plc, and several other companies all sell abl… |
| CANACCORD-GENUITY-LLC |
CANACCORD-GENUITY-LLC |
62%
|
legal, human resources, information technology, and administrative personnel, professional fees, patent fees and costs, insurance costs and other general corporate expenses. Selling, general and admi… |
| COMPANY-LLC |
COMPANY-LLC |
62%
|
legal, human resources, information technology, and administrative personnel, professional fees, patent fees and costs, insurance costs and other general corporate expenses. Selling, general and admi… |
| ROBERT-W-DUGGAN-CO |
ROBERT-W-DUGGAN-CO |
62%
|
on an ongoing basis. Although we cannot predict the ultimate impact of any such new laws, they will likely result in additional costs and may require us to change how we manufacture our products, whi… |
| TD-SECURITIES-LLC |
TD-SECURITIES-LLC |
62%
|
legal, human resources, information technology, and administrative personnel, professional fees, patent fees and costs, insurance costs and other general corporate expenses. Selling, general and admi… |